Funder
National Institutes of Health
Office of Research and Development
University of Kentucky
Subject
Histology,Physiology,Endocrinology, Diabetes and Metabolism
Reference45 articles.
1. Efficacy and safety of sodium glucose co-transport-2 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trials;Monami;Diabetes Obes. Metab.,2014
2. Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2;Ghezzi;Diabetologia,2018
3. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N. Engl. J. Med.,2015
4. Canagliflozin and cardiovascular and renal events in type 2 diabetes;Neal;N. Engl. J. Med.,2017
5. Cardiovascular safety, long-term noncardiovascular safety, and efficacy of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: a systemic review and meta-analysis with trial sequential analysis;Zhang;J. Am. Heart Assoc.,2018
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献